Tobira Therapeutics, Inc.

CIK 1311596 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tobira Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2017SC 13G/A0000315066-17-002077
Jan 18, 2017SC 13G/A0001104659-17-002759
Nov 14, 201615-12B0001193125-16-766988
Nov 9, 2016EFFECT9999999995-16-006186
Nov 9, 2016EFFECT9999999995-16-006187
Nov 4, 2016SC 13D/A0000904454-16-001545
Nov 4, 201640000904454-16-001535
Nov 3, 2016POS AM0001193125-16-759034
Nov 3, 201640001209191-16-148105
Nov 3, 2016S-8 POS0001193125-16-759044
Nov 3, 2016SC 13D/A0001193125-16-759083
Nov 3, 2016S-8 POS0001193125-16-759041
Nov 3, 201640001209191-16-148108
Nov 3, 201640000904454-16-001527
Nov 3, 2016S-8 POS0001193125-16-759056
Nov 3, 201640001209191-16-148102
Nov 3, 201640001209191-16-148103
Nov 3, 201640001209191-16-148104
Nov 3, 201640000904454-16-001531
Nov 3, 201640000904454-16-001533
Nov 3, 201640001209191-16-148099
Nov 3, 201640001209191-16-148110
Nov 3, 2016S-8 POS0001193125-16-759058
Nov 3, 2016POS AM0001193125-16-759022
Nov 3, 2016S-8 POS0001193125-16-759050